Scott D. Grimes is Director of Cardlytics, Inc.. Currently has a direct ownership of 248,779 shares of CDLX, which is worth approximately $952,823. The most recent transaction as insider was on Nov 08, 2022, when has been sold 6 shares (Common Stock) at a price of $3.92 per share, resulting in proceeds of $23. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 249K
0% 3M change
0% 12M change
Total Value Held $952,823

Scott D. Grimes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 08 2022
SELL
Open market or private sale
$23 $3.92 p/Share
6 Reduced 0.0%
248,779 Common Stock
Nov 08 2022
SELL
Open market or private sale
$1,966 $3.98 p/Share
494 Reduced 0.2%
248,785 Common Stock
Nov 07 2022
SELL
Open market or private sale
$38,888 $4.32 p/Share
9,002 Reduced 3.49%
249,279 Common Stock
Oct 06 2022
BUY
Exercise of conversion of derivative security
-
19,687 Added 7.08%
258,281 Common Stock
Aug 05 2022
SELL
Open market or private sale
$140,614 $15.19 p/Share
9,257 Reduced 3.73%
238,594 Common Stock
Jun 09 2022
BUY
Exercise of conversion of derivative security
-
19,688 Added 7.37%
247,560 Common Stock
May 05 2022
SELL
Open market or private sale
$541,092 $34.39 p/Share
15,734 Reduced 6.46%
227,872 Common Stock
Apr 19 2022
SELL
Open market or private sale
$205,269 $50.09 p/Share
4,098 Reduced 1.65%
243,606 Common Stock
Apr 06 2022
BUY
Exercise of conversion of derivative security
-
19,688 Added 7.36%
247,704 Common Stock
Apr 05 2022
BUY
Exercise of conversion of derivative security
-
3,408 Added 1.47%
228,016 Common Stock
Apr 04 2022
SELL
Open market or private sale
$343,800 $57.3 p/Share
6,000 Reduced 2.6%
224,608 Common Stock
Apr 01 2022
BUY
Exercise of conversion of derivative security
-
14,920 Added 6.08%
230,608 Common Stock
Mar 24 2022
BUY
Grant, award, or other acquisition
-
1,660 Added 0.76%
215,688 Common Stock
Mar 18 2022
SELL
Open market or private sale
$323,760 $53.96 p/Share
6,000 Reduced 2.73%
214,028 Common Stock
Mar 03 2022
SELL
Open market or private sale
$352,980 $58.83 p/Share
6,000 Reduced 2.65%
220,028 Common Stock
Feb 18 2022
SELL
Open market or private sale
$355,560 $59.26 p/Share
6,000 Reduced 2.59%
226,028 Common Stock
Feb 03 2022
SELL
Open market or private sale
$385,440 $64.24 p/Share
6,000 Reduced 2.52%
232,028 Common Stock
Jan 18 2022
SELL
Open market or private sale
$375,780 $62.63 p/Share
6,000 Reduced 2.46%
238,028 Common Stock
Jan 03 2022
SELL
Open market or private sale
$401,280 $66.88 p/Share
6,000 Reduced 2.4%
244,028 Common Stock
Dec 20 2021
SELL
Open market or private sale
$379,860 $63.31 p/Share
6,000 Reduced 2.34%
250,028 Common Stock
Dec 10 2021
SELL
Open market or private sale
$1,254,510 $68.53 p/Share
18,306 Reduced 6.67%
256,028 Common Stock
Dec 09 2021
BUY
Exercise of conversion of derivative security
-
39,375 Added 12.55%
274,334 Common Stock
Dec 03 2021
SELL
Open market or private sale
$379,080 $63.18 p/Share
6,000 Reduced 2.49%
234,959 Common Stock
Nov 18 2021
SELL
Open market or private sale
$474,960 $79.16 p/Share
6,000 Reduced 2.43%
240,959 Common Stock
Nov 05 2021
SELL
Open market or private sale
$1,662,927 $91.45 p/Share
18,184 Reduced 6.86%
246,865 Common Stock
SDG

Scott D. Grimes

Director
Atlanta, GA

Track Institutional and Insider Activities on CDLX

Follow Cardlytics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDLX shares.

Notify only if

Insider Trading

Get notified when an Cardlytics, Inc. insider buys or sells CDLX shares.

Notify only if

News

Receive news related to Cardlytics, Inc.

Track Activities on CDLX